Resource library

This report outline the findings and recommendations from the National Standard Medication Chart (NSMC) national audit conducted in 2018.

This report outlines the findings and recommendations of the National Standard Medication Chart (NSMC) national audit 2018. Where appropriate, the report also references previous audits of the National Inpatient Medication Chart (NIMC).

The Pharmaceutical Benefits Scheme Hospital Medication Chart (PBS HMC) enables the prescribing, administering, supply and claiming of eligible PBS and non-PBS medicines without the need to issue a separate prescription.

Consultation on this discussion paper closed 5 July 2019.

A safety statement recommending that established metered dose inhalers are prescribed and communicated by the metered dose.

In 2019, Professor Lynne Emmerton led the review of name similarity for:

• Monoclonal antibodies (MABs) (commonly ending in the suffix ‘mab’)
• Tyrosine kinase (factor) inhibitors (TKIs) (commonly ending in the suffix ‘nib’).

This included the theoretical risk of confusion within these classes of medicines in clinical practice, including the similarity in clinical indication, with a view to producing a specialised list of medicines. The results of this review can be found in this publication.